No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs373546892 |
chr20:29521718-29521719 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs190986093 |
chr20:29521721-29521722 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs537131819 |
chr20:29521738-29521739 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs534688373 |
chr20:29521771-29521772 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs143324108 |
chr20:29521772-29521773 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536266199 |
chr20:29521869-29521870 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs556063474 |
chr20:29521889-29521890 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs183258283 |
chr20:29521896-29521897 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs377582616 |
chr20:29521917-29521918 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs188122547 |
chr20:29521918-29521919 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs34619750 |
chr20:29521919-29521920 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs377692953 |
chr20:29521923-29521924 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs578140372 |
chr20:29521961-29521962 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs6118970 |
chr20:29521964-29521965 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
15 |
rs557038084 |
chr20:29521968-29521969 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs573657146 |
chr20:29521999-29522000 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs6118971 |
chr20:29522024-29522025 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
18 |
rs1064148 |
chr20:29522049-29522050 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148544598 |
chr20:29522078-29522079 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs528363855 |
chr20:29522089-29522090 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs190415533 |
chr20:29522092-29522093 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs142862805 |
chr20:29522107-29522108 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs565079104 |
chr20:29522109-29522110 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs530623450 |
chr20:29522130-29522131 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs550658577 |
chr20:29522175-29522176 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs567387529 |
chr20:29522230-29522231 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs182961132 |
chr20:29522239-29522240 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs375541255 |
chr20:29522240-29522241 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs187604720 |
chr20:29522242-29522243 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs566380568 |
chr20:29522247-29522248 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs535318732 |
chr20:29522259-29522260 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs563562776 |
chr20:29522270-29522271 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs571764738 |
chr20:29522295-29522296 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs192548147 |
chr20:29522313-29522314 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs183473301 |
chr20:29522325-29522326 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs573818087 |
chr20:29522339-29522340 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs151043354 |
chr20:29522340-29522341 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs368225001 |
chr20:29522354-29522355 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs573194643 |
chr20:29522369-29522370 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs117284715 |
chr20:29522373-29522374 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs200920440 |
chr20:29522380-29522381 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs575542587 |
chr20:29522392-29522393 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs545655546 |
chr20:29522408-29522409 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs187863078 |
chr20:29522435-29522436 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs56034052 |
chr20:29522449-29522450 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs397741109 |
chr20:29522452-29522453 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs544442488 |
chr20:29522468-29522469 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs561096791 |
chr20:29522473-29522474 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs529799340 |
chr20:29522512-29522513 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs140919194 |
chr20:29522514-29522515 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|